170 related articles for article (PubMed ID: 32880111)
21. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
Blanc JF; Frulio N; Chiche L; Sempoux C; Annet L; Hubert C; Gouw AS; de Jong KP; Bioulac-Sage P; Balabaud C
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):180-7. PubMed ID: 25434466
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular Adenomas: Morphology and Genomics.
Bioulac-Sage P; Sempoux C; Balabaud C
Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
[TBL] [Abstract][Full Text] [Related]
23. Molecular classification of hepatocellular adenoma in clinical practice.
Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
[TBL] [Abstract][Full Text] [Related]
24. [Benign liver tumors].
Cherqui D
J Chir (Paris); 2001 Feb; 138(1):19-26. PubMed ID: 11240457
[TBL] [Abstract][Full Text] [Related]
25. [Differential diagnosis and therapy of benign liver tumors].
Jonas S; Vogl TJ; Schwarz W; Neuhaus P
Ther Umsch; 1998 Feb; 55(2):120-6. PubMed ID: 9545855
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis.
Hussain SM; van den Bos IC; Dwarkasing RS; Kuiper JW; den Hollander J
Eur Radiol; 2006 Sep; 16(9):1873-86. PubMed ID: 16708218
[TBL] [Abstract][Full Text] [Related]
27. Benign liver tumours: understanding molecular physiology to adapt clinical management.
Nault JC; Paradis V; Ronot M; Zucman-Rossi J
Nat Rev Gastroenterol Hepatol; 2022 Nov; 19(11):703-716. PubMed ID: 35835851
[TBL] [Abstract][Full Text] [Related]
28. [Malignant transformation of multiple isolated hepatocellular adenomas. Therapeutic implications of immunohistochemical and radiological findings].
Baulieux J; Manichon AF; Bancel B; D'Errico E; Raspado O; Ducerf C; Mabrut JY; Rode A
Bull Acad Natl Med; 2012 Feb; 196(2):459-81; discussion 482-3. PubMed ID: 23420963
[TBL] [Abstract][Full Text] [Related]
29. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
30. Gene mutations in hepatocellular adenomas.
Raft MB; Jørgensen EN; Vainer B
Histopathology; 2015 Jun; 66(7):910-21. PubMed ID: 25195525
[TBL] [Abstract][Full Text] [Related]
31. Benign liver tumors: an update.
Paradis V
Clin Liver Dis; 2010 Nov; 14(4):719-29. PubMed ID: 21055692
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular adenoma: Classification, variants and clinical relevance.
Bioulac-Sage P; Sempoux C; Balabaud C
Semin Diagn Pathol; 2017 Mar; 34(2):112-125. PubMed ID: 28131467
[TBL] [Abstract][Full Text] [Related]
33. [Multiple large hepatocellular adenomas in a patient with glycogen storage disease type Ia].
Uemura S; Ariizumi S; Takahashi Y; Omori A; Kotera Y; Katagiri S; Hashimoto E; Nakano M; Yamamoto M
Nihon Shokakibyo Gakkai Zasshi; 2014 Apr; 111(4):787-96. PubMed ID: 24769469
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
[TBL] [Abstract][Full Text] [Related]
35. Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.
Pilati C; Letouzé E; Nault JC; Imbeaud S; Boulai A; Calderaro J; Poussin K; Franconi A; Couchy G; Morcrette G; Mallet M; Taouji S; Balabaud C; Terris B; Canal F; Paradis V; Scoazec JY; de Muret A; Guettier C; Bioulac-Sage P; Chevet E; Calvo F; Zucman-Rossi J
Cancer Cell; 2014 Apr; 25(4):428-41. PubMed ID: 24735922
[TBL] [Abstract][Full Text] [Related]
36. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
[TBL] [Abstract][Full Text] [Related]
37. Management of focal nodular hyperplasia and hepatocellular adenoma.
Mentha G; Rubbia-Brandt L; Howarth N; Majno P; Morel P; Terrier F
Swiss Surg; 1999; 5(3):122-5. PubMed ID: 10414183
[TBL] [Abstract][Full Text] [Related]
38. [Hepatocellular adenoma in 20 patients; recommendations for treatment].
de Wilt JH; de Man RA; Laméris JS; Zondervan PE; Tilanus HW; IJzermans JN
Ned Tijdschr Geneeskd; 1998 Nov; 142(45):2459-63. PubMed ID: 10028326
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of benign liver nodules: Brazilian Society of Hepatology (SBH) recommendations.
Strauss E; Ferreira Ade S; França AV; Lyra AC; Barros FM; Silva I; Garcia JH; Parise ER
Arq Gastroenterol; 2015 Dec; 52 Suppl 1():47-54. PubMed ID: 26959805
[TBL] [Abstract][Full Text] [Related]
40. Management of hepatocellular adenoma during pregnancy.
Noels JE; van Aalten SM; van der Windt DJ; Kok NF; de Man RA; Terkivatan T; Ijzermans JN
J Hepatol; 2011 Mar; 54(3):553-8. PubMed ID: 21094555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
